Inflammatory Phenotypes In Severe Pneumonia: Clinical Evidence To Mouse Models For Precision Therapeutics

Area of Science:

• Critical care medicine
• Translational research
• Immunology

Background:

• Sepsis and ARDS exhibit hyper- and hypoinflammatory phenotypes, but their role in severe pneumonia requires further investigation.
• Understanding these phenotypes is crucial for developing precision therapies for critical illnesses.

Purpose of the Study:

• To identify and characterize hyper- and hypoinflammatory phenotypes in critically ill pneumonia patients using biomarkers.
• To validate these phenotypes in a mouse model of bacterial pneumonia.
• To assess differential responses to therapeutic interventions based on identified phenotypes.

Main Methods:

• Latent class analysis (LCA) was used to identify inflammatory phenotypes in 548 ICU patients with pulmonary sepsis.
• A mouse model of pneumococcal pneumonia was developed to mirror human phenotypes.
• Therapeutic responses to dexamethasone and IL-6 receptor blockade were tested in the mouse model.

Main Results:

• Two distinct phenotypes were identified in patients: hyperinflammatory (increased lung injury, mortality) and hypoinflammatory (favorable outcomes).
• The mouse model also exhibited two phenotypes with differing lung injury and mortality trajectories.
• Anti-inflammatory treatments showed efficacy solely in the hyperinflammatory mouse phenotype.

Conclusions:

• This study establishes a translational framework linking human and mouse data for phenotype-targeted critical care therapies.
• Findings support the development of precision medicine approaches for severe pneumonia.
• The results aim to improve patient outcomes through tailored therapeutic strategies.